High-throughput structure determination using nucleic acid calipers

Patent metadata

Field	Value
Publication number	US-9897597-B2
Application number	US-201515305399-A
Country	US
Kind code	B2
Filing date	Apr 23, 2015
Priority date	Apr 23, 2014
Publication date	Feb 20, 2018
Grant date	Feb 20, 2018

Abstract

Provided herein are compositions and methods for determining the structure of individual targets using nucleic acid caliper by determining long-range distances within such targets.

First claim

What is claimed is:

1. A system comprising
(a) a single-stranded nucleic acid caliper having a reference domain and a target domain, wherein from 5′ to 3′ or 3′ to 5′ the single-stranded nucleic acid caliper comprises
(1) a reference domain comprising
(i) a nucleotide sequence RS2 that is complementary to a reference splint,
(ii) a nucleotide sequence RR2 that is complementary to a nucleic acid handle RH2 that flanks a reference molecule,
(iii) a reference domain sequence,
(iv) a nucleotide sequence RR1 that is complementary to a nucleic acid handle RH1 that flanks the reference molecule, and
(v) a nucleotide sequence RS1 that is complementary to the reference splint; and

(2) a target domain comprising
(i) a nucleotide sequence TS2 that is complementary to a target splint,
(ii) a nucleotide sequence TT2 that is complementary to a nucleic acid handle TH2 that flanks a target,
(iii) a target domain sequence,
(iv) a nucleotide sequence TT1 that is complementary to a nucleic acid handle TH1 that flanks the target, and
(v) a nucleotide sequence TS1 that is complementary to the target splint;

(b) the reference splint that is a single-stranded oligonucleotide comprising partial sequence complementarity to the single-stranded nucleic acid caliper at the nucleotide sequences RS2 and RS1, and a RS toehold sequence that remains single-stranded when the reference splint is bound to the single-stranded nucleic acid caliper;
(c) the target splint that is a single-stranded oligonucleotide comprising partial sequence complementarity to the single-stranded nucleic acid caliper at the nucleotide sequences TS2 and TS1, and a TS toehold sequence that remains single-stranded when the target splint is bound to the single-stranded nucleic acid caliper; and
(d) a reference molecule flanked by two single-stranded nucleic acid handles, RH1 and RH2,
wherein the reference domain is configured to form a loop when hybridized to the reference splint and/or the reference molecule, and the target domain is configured to form a loop when hybridized to the target splint and/or to the target; and
wherein the nucleic acid caliper is configured to be attached to a solid surface.

2. The system of claim 1 , further comprising the target flanked by two single-stranded nucleic acid handles, TH1 and TH2.

3. The system of claim 1 , wherein the single-stranded caliper is conjugated to a bead at a first end.

4. A method of use of the system of claim 1 comprising
(a) measuring, under tension, a bead-to-surface distance of the nucleic acid caliper of claim 1 attached to a surface on a first end and to a bead on a second end, when bound to the reference molecule, the target flanked by single-stranded nucleic acid handles TH1 and TH2, and the target splint but not bound to a reference splint (BSD-ref),
(b) removing the target splint from the nucleic acid caliper and hybridizing the reference splint to the nucleic acid caliper,
(c) measuring, under tension, the bead-to-surface distance of the nucleic acid caliper, when bound to the reference molecule, the target flanked by single-stranded nucleic acid handles TH1 and TH2, the reference splint but not bound to the target splint (BSD-target), and
(d) determining the difference between BSD-target and BSD-ref as a measure of the distance between points of attachment of the single-stranded nucleic acid handles bound to the target when the target is in its native (non-denatured) conformation.

5. The method of claim 4 , further comprising measuring, under tension and denaturing conditions, the bead-to-surface distance of the nucleic acid caliper, when bound to the target, the reference molecule and the reference splint, to obtain the distance between points of attachment of the single-stranded nucleic acid handles bound to the target when the target is in its denatured conformation.

6. The method of claim 4 , wherein the target is a protein.

7. The method of claim 4 , wherein the target is a nucleic acid nanostructure.

8. The method of claim 7 , further comprising measuring, under tension and in the presence of a first displacement nucleic acid, the bead-to-surface distance of the nucleic acid caliper, when bound to the target, the reference molecule, the reference splint, and the first displacement nucleic acid, to identify a first point of attachment of the single-stranded nucleic acid handles to the target.

9. The method of claim 8 , further comprising measuring, under tension and in the presence of a second displacement nucleic acid, the bead-to-surface distance of the nucleic acid caliper, when bound to the target, the reference molecule, the reference splint, and the second displacement nucleic acid, to identify a second point of attachment of the single-stranded nucleic acid handles to the target.

10. The system of claim 1 , wherein the single-stranded caliper is conjugated to a bead at a first end and to a surface at a second end.

11. The system of claim 10 , wherein the bead is a microbead.

12. The system of claim 10 , wherein the bead is a magnetic bead.

13. The system of claim 1 , wherein the caliper is attached to a fixed surface.

14. The system of claim 1 , further comprising a RS displacement strand that is complementary to the sequence of the RS toehold sequence.

15. The system of claim 1 , further comprising a TS displacement strand that is complementary to the sequence of the TS toehold sequence.

16. The system of claim 1 , wherein the target is a protein.

17. The system of claim 1 , wherein the target is a protein of known primary amino acid sequence.

18. The system of claim 1 , wherein the target is a protein of unknown primary amino acid sequence.

19. The system of claim 1 , wherein the target is a protein bound to a binding partner.

20. The system of claim 1 , wherein the single-stranded handles, TH1 and TH2, are attached to the target at unmodified surface lysines.

21. The system of claim 1 , wherein the target is a nucleic acid nanostructure.

22. The system of claim 1 , wherein the single-stranded handles, TH1 and TH2, each comprise a hairpin barcode sequence and a loop sequence, wherein the hairpin barcode sequence is identical between TH1 and TH2, and the loop sequence is of different length between TH1 and TH2.

23. The system of claim 1 , wherein the single-stranded handles, TH1 and TH2, each comprise a barcode sequence.

24. The system of claim 23 , wherein the barcode sequence is accessible via strand displacement.

25. The system of claim 23 , wherein the barcode sequence is present in a nested loop.

26. A plurality of systems of claim 1 , wherein the reference molecule, the reference splint, the RS1, RS2, RH1, RH2, RR1, RR2, TS1, TS2, TT1, TT2, TH1, TH2, TS toehold and RS toehold are identical between species in the plurality.

27. The plurality of systems of claim 26 , wherein the single-stranded nucleic acid calipers are attached to a surface at a first end and to a bead at a second end.

28. The plurality of systems of claim 26 , wherein the single-stranded nucleic acid calipers each comprises a unique sequence that forms a unique length looped structure.

Assignees

• Childrens Medical Center
• Dana Farber Cancer Inst Inc
• Dana Farber Cancer Inst Inc

Inventors

• Shih William M
• Wong Wesley Philip

Classifications

• C12Q1/68 Primary

  involving nucleic acids · CPC title

• C12Q1/6804

  Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title

• G01N33/54333 Primary

  Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction · CPC title

• G01N2458/10

  Oligonucleotides as tagging agents for labelling antibodies · CPC title

• C12Q2525/204

  specific length of the oligonucleotides · CPC title